Bradykinin Receptor Antagonists [antagonisté bradykininových receptorů]

topical
10
Terms

antagonisté bradykininu
antagonisté receptorů bradykininu
blokátory bradykininových receptorů
inhibitory bradykininových receptorů

 

Bradykinin Antagonist
Bradykinin Antagonists
Bradykinin Receptor Antagonist
Bradykinin Receptor Blocker
Bradykinin Receptor Blockers
Bradykinin Receptor Inhibitor
Bradykinin Receptor Inhibitors

Persistent link   https://www.medvik.cz/link/D065168
Definition

Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS.

DUI
D065168 MeSH Browser
CUI
M0587714
Previous indexing
Bradykinin Receptor/ Antagonists & Inhibitors (1994-2014); Bradykinin Receptor/ Antoagonists & Inhibitors (1994-2014)
History note
2015
Public note
2015

Allowable subheadings

AD
administration & dosage 4
AE
adverse effects 3
AN
analysis
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry
CL
classification 1
EC
economics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics
PD
pharmacology 1
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use 5
TO
toxicity
UR
urine

D Chemicals and Drugs
D01 Inorganic Chemicals 68
D02 Organic Chemicals 391
D03 Heterocyclic Compounds 189
D04 Polycyclic Compounds 65
D05 Macromolecular Substances 103
D06 Hormones, Hormone Substitutes, and Hormone Antagonists 43
D08 Enzymes and Coenzymes 7
D09 Carbohydrates 723
D10 Lipids 2 524
D12 Amino Acids, Peptides, and Proteins 16
D13 Nucleic Acids, Nucleotides, and Nucleosides 9
D20 Complex Mixtures 19
D23 Biological Factors 143
D25 Biomedical and Dental Materials 110
D26 Pharmaceutical Preparations 7 034
D27 Chemical Actions and Uses 374
D27.505 Pharmacologic Actions 408
D27.505.519 Molecular Mechanisms of Pharmacological Action 89
D27.505.519.124 Alkylating Agents 91
D27.505.519.143 Amylin Receptor Agonists
D27.505.519.162 Angiotensin Receptor Antagonists 222
D27.505.519.170 Antacids 162
D27.505.519.174 Antidiuretic Hormone Receptor Antagonists 28
D27.505.519.178 Antifoaming Agents 12
D27.505.519.182 Antiglycation Agents
D27.505.519.186 Antimetabolites 120
D27.505.519.217 Antioxidants 2 520
D27.505.519.241 Aversive Agents
D27.505.519.265 Bradykinin Receptor Antagonists 10
D27.505.519.265.249 Bradykinin B1 Receptor Antagonists
D27.505.519.265.500 Bradykinin B2 Receptor Antagonists 7
D27.505.519.270 Calcitonin Gene-Related Peptide Receptor Antagonists 72
D27.505.519.275 CCR5 Receptor Antagonists 4
D27.505.519.295 Cerumenolytic Agents 1
D27.505.519.334 Cystine Depleting Agents
D27.505.519.349 Cytochrome P-450 Enzyme Inducers 10
D27.505.519.364 Endothelin Receptor Antagonists 119
D27.505.519.374 Enzyme Activators 30
D27.505.519.389 Enzyme Inhibitors 873
D27.505.519.405 Enzyme Reactivators 16
D27.505.519.421 Fibrin Modulating Agents 2
D27.505.519.452 Heparin Antagonists 23
D27.505.519.507 Immune Checkpoint Inhibitors 328
D27.505.519.562 Membrane Transport Modulators 22
D27.505.519.593 Mitosis Modulators 3
D27.505.519.625 Neurotransmitter Agents 517
D27.505.519.656 Nitric Oxide Donors 63
D27.505.519.828 Peptidomimetics 11
D27.505.519.871 Radiopharmaceuticals 806
D27.505.519.914 Sequestering Agents 1
D27.505.519.936 Sodium-Glucose Transporter 2 Inhibitors 783
D27.505.519.947 Sphingosine 1 Phosphate Receptor Modulators 25
D27.505.519.952 Toll-Like Receptor Agonists
D27.505.519.957 Viral Fusion Protein Inhibitors

Add

Narrower terms